ArticleBlood cancer journal2025

Immune profiling of smoldering multiple myeloma patients treated in a phase lb study of PVX-410 vaccine targeting XBP1/CD138/CS1 antigens, and citarinostat, a histone deacetylase inhibitor (HDACi) with and without lenalidomide.

Diana Cirstea et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.